{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:59:06Z","timestamp":1778011146698,"version":"3.51.4"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2019,2,27]]},"DOI":"10.1007\/s00134-019-05520-5","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T10:56:57Z","timestamp":1547809017000},"page":"172-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":204,"title":["Rationalizing antimicrobial therapy in the ICU: a narrative review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-7383","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"first","affiliation":[]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[]},{"given":"Olaf","family":"Cremer","sequence":"additional","affiliation":[]},{"given":"George","family":"Daikos","sequence":"additional","affiliation":[]},{"given":"Jan","family":"de Waele","sequence":"additional","affiliation":[]},{"given":"Andre","family":"Kallil","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Kipnis","sequence":"additional","affiliation":[]},{"given":"Marin","family":"Kollef","sequence":"additional","affiliation":[]},{"given":"Kevin","family":"Laupland","sequence":"additional","affiliation":[]},{"given":"Jose-Artur","family":"Paiva","sequence":"additional","affiliation":[]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[]},{"given":"\u00c9tienne","family":"Rupp\u00e9","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Salluh","sequence":"additional","affiliation":[]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Weiss","sequence":"additional","affiliation":[]},{"given":"Fran\u00e7ois","family":"Barbier","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"issue":"6","key":"5520_CR1","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","volume":"6","author":"A Versporten","year":"2018","unstructured":"Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M et al (2018) Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health 6(6):e619\u2013e629","journal-title":"Lancet Glob Health"},{"issue":"4","key":"5520_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/CCM.0000000000002253","volume":"45","author":"M Detsis","year":"2017","unstructured":"Detsis M, Karanika S, Mylonakis E (2017) ICU acquisition rate, risk factors, and clinical significance of digestive tract colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis. Crit Care Med 45(4):705\u2013714","journal-title":"Crit Care Med"},{"issue":"10","key":"5520_CR3","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","volume":"42","author":"MH Kollef","year":"2014","unstructured":"Kollef MH, Chastre J, Fagon JY, Francois B, Niederman MS, Rello J et al (2014) Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med 42(10):2178\u20132187","journal-title":"Crit Care Med"},{"issue":"4","key":"5520_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3201\/eid2404.171461","volume":"24","author":"SN Bulens","year":"2018","unstructured":"Bulens SN, Yi SH, Walters MS, Jacob JT, Bower C, Reno J et al (2018) Carbapenem-nonsusceptible Acinetobacter baumannii, 8 US metropolitan areas, 2012-2015. Emerg Infect Dis 24(4):727\u2013734","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5520_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00042-16","volume":"30","author":"LY Hsu","year":"2017","unstructured":"Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA (2017) Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev 30(1):1\u201322","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"5520_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1099\/jmm.0.000328","volume":"65","author":"CH Rodriguez","year":"2016","unstructured":"Rodriguez CH, Balderrama Yarhui N, Nastro M, Nunez Quezada T, Castro Canarte G, Magne Ventura R et al (2016) Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America. J Med Microbiol 65(10):1088\u20131091","journal-title":"J Med Microbiol"},{"issue":"12","key":"5520_CR7","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/jac\/dkx322","volume":"72","author":"J Nowak","year":"2017","unstructured":"Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J et al (2017) High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother 72(12):3277\u20133282","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5520_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jgar.2015.05.005","volume":"3","author":"SH Lob","year":"2015","unstructured":"Lob SH, Biedenbach DJ, Badal RE, Kazmierczak KM, Sahm DF (2015) Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011-2013. J Glob Antimicrob Resist 3(3):190\u2013197","journal-title":"J Glob Antimicrob Resist"},{"issue":"8","key":"5520_CR9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/cid\/cix893","volume":"66","author":"RA Bonomo","year":"2018","unstructured":"Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA et al (2018) Carbapenemase-producing organisms: a global scourge. Clini Infect Dis 66(8):1290\u20131297","journal-title":"Clini Infect Dis"},{"issue":"12","key":"5520_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ajic.2016.08.007","volume":"44","author":"VD Rosenthal","year":"2016","unstructured":"Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SAA, Leblebicioglu H, Mehta Y et al (2016) International nosocomial infection control consortium report, data summary of 50 countries for 2010\u20132015: device-associated module. Am J Infect Control 44(12):1495\u20131504","journal-title":"Am J Infect Control"},{"issue":"11","key":"5520_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ et al (2016) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 37(11):1288\u20131301","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"5520_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4103\/0366-6999.201601","volume":"130","author":"L Gao","year":"2017","unstructured":"Gao L, Lyu Y, Li Y (2017) Trends in drug resistance of Acinetobacter baumannii over a 10-year period: nationwide data from the China surveillance of antimicrobial resistance program. Chin Med J (Engl) 130(6):659\u2013664","journal-title":"Chin Med J (Engl)"},{"key":"5520_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy543","author":"A Bonell","year":"2018","unstructured":"Bonell A, Azarrafiy R, Huong VTL, Viet TL, Phu VD, Dat VQ et al (2018) A systematic review and meta-analysis of ventilator associated pneumonia in adults in Asia; an analysis of national income level on incidence and etiology. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciy543","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"5520_CR14","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","volume":"22","author":"FP Hu","year":"2016","unstructured":"Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC et al (2016) Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect 22(Suppl 1):S9\u2013S14","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"5520_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cmi.2016.01.026","volume":"22","author":"R Bitterman","year":"2016","unstructured":"Bitterman R, Hussein K, Leibovici L, Carmeli Y, Paul M (2016) Systematic review of antibiotic consumption in acute care hospitals. Clin Microbiol Infect 22(6):561","journal-title":"Clin Microbiol Infect"},{"issue":"10014","key":"5520_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A et al (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387(10014):176\u2013187","journal-title":"Lancet"},{"issue":"12","key":"5520_CR17","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00134-016-4543-9","volume":"42","author":"F Barbier","year":"2016","unstructured":"Barbier F, Luyt CE (2016) Understanding resistance. Intensive Care Med 42(12):2080\u20132083","journal-title":"Intensive Care Med"},{"key":"5520_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13613-015-0061-0","volume":"5","author":"E Rupp\u00e9","year":"2015","unstructured":"Rupp\u00e9 E, Woerther PL, Barbier F (2015) Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 5:21","journal-title":"Ann Intensive Care"},{"issue":"11","key":"5520_CR19","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/jac\/dkx273","volume":"72","author":"M Abdallah","year":"2017","unstructured":"Abdallah M, Badawi M, Amirah MF, Rasheed A, Mady AF, Alodat M et al (2017) Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU. J Antimicrob Chemother 72(11):3187\u20133190","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5520_CR20","doi-asserted-by":"crossref","first-page":"20088","DOI":"10.2807\/ese.17.07.20088-en","volume":"17","author":"A Zagorianou","year":"2012","unstructured":"Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S et al (2012) Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004\u20132010. Euro Surveill 17(7):20088","journal-title":"Euro Surveill"},{"issue":"3","key":"5520_CR21","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/cc9062","volume":"14","author":"E Meyer","year":"2010","unstructured":"Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001\u20132008. Crit Care 14(3):R113","journal-title":"Crit Care"},{"issue":"3","key":"5520_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1179\/joc.2006.18.3.261","volume":"18","author":"M Bassetti","year":"2006","unstructured":"Bassetti M, Cruciani M, Righi E, Rebesco B, Fasce R, Costa A et al (2006) Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit. J Chemother 18(3):261\u2013267","journal-title":"J Chemother"},{"issue":"9","key":"5520_CR23","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10096-014-2097-8","volume":"33","author":"G Samonis","year":"2014","unstructured":"Samonis G, Korbila IP, Maraki S, Michailidou I, Vardakas KZ, Kofteridis D et al (2014) Trends in isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use un a tertiary hospital. Eur J Clin Microbiol Infect Dis 33(9):1505\u20131510","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"5520_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jhin.2009.11.021","volume":"75","author":"TS Jacoby","year":"2010","unstructured":"Jacoby TS, Kuchenbecker RS, Dos Santos RP, Magedanz L, Guzatto P, Moreira LB (2010) Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J Hosp Infect 75(1):23\u201327","journal-title":"J Hosp Infect"},{"issue":"5","key":"5520_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijantimicag.2015.07.010","volume":"46","author":"V Fihman","year":"2015","unstructured":"Fihman V, Messika J, Hajage D, Tournier V, Gaudry S, Magdoud F et al (2015) Five-year trends for ventilator-associated pneumonia: correlation between microbiological findings and antimicrobial drug consumption. Int J Antimicrob Agents 46(5):518\u2013525","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"5520_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkr137","volume":"66","author":"R Kaki","year":"2011","unstructured":"Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66(6):1223\u20131230","journal-title":"J Antimicrob Chemother"},{"key":"5520_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:13","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5520_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-009-1714-y","volume":"36","author":"S Nijssen","year":"2010","unstructured":"Nijssen S, Fluit AC, van de Vijver D, Top J, Willems R, Bonten MJM (2010) Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant Gram-negative bacteria. Intensive Care Med 36(3):512\u2013519","journal-title":"Intensive Care Med"},{"issue":"1","key":"5520_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cmi.2017.09.017","volume":"24","author":"E Ruppe","year":"2018","unstructured":"Ruppe E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A et al (2018) Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage. Clin Microbiol Infect 24(1):3\u20135","journal-title":"Clin Microbiol Infect"},{"issue":"6285","key":"5520_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.aad9382","volume":"352","author":"EG Pamer","year":"2016","unstructured":"Pamer EG (2016) Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352(6285):535\u2013538","journal-title":"Science"},{"issue":"11","key":"5520_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00134-012-2675-0","volume":"38","author":"K Razazi","year":"2012","unstructured":"Razazi K, Derde LP, Verachten M, Legrand P, Lesprit P, Brun-Buisson C (2012) Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 38(11):1769\u20131778","journal-title":"Intensive Care Med"},{"issue":"3","key":"5520_CR32","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1128\/AAC.02101-15","volume":"60","author":"S Poignant","year":"2015","unstructured":"Poignant S, Guinard J, Guiguon A, Bret L, Poisson D-M, Boulain T et al (2015) Risk factors and outcomes of intestinal carriage of AmpC-hyperproducing Enterobacteriaceae in ICU patients. Antimicrob Agents Chemother 60(3):1883\u20131887","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5520_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jhin.2017.08.024","volume":"98","author":"D Hilliquin","year":"2018","unstructured":"Hilliquin D, Le Guern R, Thepot Seegers V, Neulier C, Lomont A, Marie V et al (2018) Risk factors for acquisition of OXA-48-producing Klebsiella pneumoniae among contact patients: a multicentre study. J Hosp Infect 98(3):253\u2013259","journal-title":"J Hosp Infect"},{"issue":"12","key":"5520_CR34","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1093\/jac\/dks316","volume":"67","author":"M Papadimitriou-Olivgeris","year":"2012","unstructured":"Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED et al (2012) Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 67(12):2976\u20132981","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5520_CR35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00134-018-5079-y","volume":"44","author":"BK Tan","year":"2018","unstructured":"Tan BK, Vivier E, Ait Bouziad K, Zahar JR, Pommier C, Parmeland L et al (2018) A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in the intensive care unit. Intensive Care Med 44(5):672\u2013673","journal-title":"Intensive Care Med"},{"issue":"3","key":"5520_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/jac\/dkt403","volume":"69","author":"P Grohs","year":"2014","unstructured":"Grohs P, Kerneis S, Sabatier B, Lavollay M, Carbonnelle E, Rostane H et al (2014) Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime. J Antimicrob Chemother 69(3):786\u2013789","journal-title":"J Antimicrob Chemother"},{"key":"5520_CR37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ijantimicag.2018.08.026","volume":"52","author":"PL Woerther","year":"2018","unstructured":"Woerther PL, Lepeule R, Burdet C, Decousser JW, Ruppe E, Barbier F (2018) Carbapenems and alternative beta-lactams for the treatment of infections due to ESBL-producing Enterobacteriaceae: what impact on intestinal colonization resistance? Int J Antimicrob Agents 52:762\u2013770","journal-title":"Int J Antimicrob Agents"},{"issue":"28","key":"5520_CR38","doi-asserted-by":"publisher","first-page":"e1100","DOI":"10.1097\/MD.0000000000001100","volume":"94","author":"KC Kao","year":"2015","unstructured":"Kao KC, Chen CB, Hu HC, Chang HC, Huang CC, Huang YC (2015) Risk factors of methicillin-resistant Staphylococcus aureus infection and correlation with nasal colonization based on molecular genotyping in medical intensive care units: a prospective observational study. Medicine (Baltimore) 94(28):e1100","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"5520_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/CCM.0b013e3182a66bb8","volume":"42","author":"PD Ziakas","year":"2014","unstructured":"Ziakas PD, Anagnostou T, Mylonakis E (2014) The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU setting: a meta-analysis of published studies. Crit Care Med 42(2):433\u2013444","journal-title":"Crit Care Med"},{"key":"5520_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","volume":"7","author":"G Raman","year":"2018","unstructured":"Raman G, Avendano EE, Chan J, Merchant S, Puzniak L (2018) Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 7:79","journal-title":"Antimicrob Resist Infect Control"},{"key":"5520_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy864","author":"JR Zahar","year":"2018","unstructured":"Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S et al (2018) Screening for intestinal carriage of ESBL-producing Enterobacteriaceae in critically ill patients: expected benefits and evidence-based controversies. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciy864","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5520_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.athoracsur.2016.12.041","volume":"103","author":"M Mazzeffi","year":"2017","unstructured":"Mazzeffi M, Gammie J, Taylor B, Cardillo S, Haldane-Lutterodt N, Amoroso A et al (2017) Healthcare-associated infections in cardiac surgery patients with prolonged intensive care unit stay. Ann Thorac Surg 103(4):1165\u20131170","journal-title":"Ann Thorac Surg"},{"issue":"14","key":"5520_CR43","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2016.2691","volume":"315","author":"LA van Vught","year":"2016","unstructured":"van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J et al (2016) Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315(14):1469\u20131479","journal-title":"JAMA"},{"issue":"12","key":"5520_CR44","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","volume":"38","author":"A Tabah","year":"2012","unstructured":"Tabah A, Koulenti D, Laupland K, Misset B, Valles J, de Bruzzi Carvalho F et al (2012) Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38(12):1930\u20131945","journal-title":"Intensive Care Med"},{"issue":"9","key":"5520_CR45","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/CCM.0000000000002512","volume":"45","author":"SA Sterling","year":"2017","unstructured":"Sterling SA, Puskarich MA, Glass AF, Guirgis F, Jones AE (2017) The impact of the Sepsis-3 septic shock definition on previously defined septic shock patients. Crit Care Med 45(9):1436\u20131442","journal-title":"Crit Care Med"},{"issue":"1","key":"5520_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13054-018-2091-0","volume":"22","author":"R Ferrer","year":"2018","unstructured":"Ferrer R, Martinez ML, Goma G, Suarez D, Alvarez-Rocha L, de la Torre MV et al (2018) Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study. Crit Care 22(1):167","journal-title":"Crit Care"},{"issue":"7","key":"5520_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856\u2013863","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"5520_CR48","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235\u20132244","journal-title":"N Engl J Med"},{"issue":"3","key":"5520_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304\u2013377","journal-title":"Intensive Care Med"},{"issue":"1","key":"5520_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/CCM.0b013e31822f061d","volume":"40","author":"KB Laupland","year":"2012","unstructured":"Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E et al (2012) Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med 40(1):145\u2013151","journal-title":"Crit Care Med"},{"issue":"5","key":"5520_CR51","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/CCM.0000000000002953","volume":"46","author":"SW Lam","year":"2018","unstructured":"Lam SW, Bauer SR, Fowler R, Duggal A (2018) Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies. Crit Care Med 46(5):684\u2013690","journal-title":"Crit Care Med"},{"issue":"1","key":"5520_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M et al (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 18(1):95\u2013107","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5520_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/CCM.0000000000002752","volume":"46","author":"F van Someren Greve","year":"2018","unstructured":"van Someren Greve F, Juffermans NP, Bos LDJ, Binnekade JM, Braber A, Cremer OL et al (2018) Respiratory viruses in invasively ventilated critically ill patients\u2014a prospective multicenter observational study. Crit Care Med 46(1):29\u201336","journal-title":"Crit Care Med"},{"key":"5520_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcv.2017.04.001","volume":"91","author":"P Loubet","year":"2017","unstructured":"Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX et al (2017) Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol 91:52\u201357","journal-title":"J Clin Virol"},{"issue":"8","key":"5520_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"4","key":"5520_CR56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7326\/M17-2820","volume":"168","author":"SM Fernando","year":"2018","unstructured":"Fernando SM, Tran A, Taljaard M, Cheng W, Rochwerg B, Seely AJE et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168(4):266\u2013275","journal-title":"Ann Intern Med"},{"issue":"3","key":"5520_CR57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.chest.2016.10.057","volume":"151","author":"JM Williams","year":"2017","unstructured":"Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AFT, Lipman J (2017) Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest 151(3):586\u2013596","journal-title":"Chest"},{"key":"5520_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13054-015-1035-1","volume":"19","author":"PM Klein Klouwenberg","year":"2015","unstructured":"Klein Klouwenberg PM, Cremer OL, van Vught LA, Ong DS, Frencken JF, Schultz MJ et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319","journal-title":"Crit Care"},{"issue":"10","key":"5520_CR59","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","volume":"12","author":"T Hranjec","year":"2012","unstructured":"Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD et al (2012) Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 12(10):774\u2013780","journal-title":"Lancet Infect Dis"},{"key":"5520_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-4939-1776-1_15","volume":"1237","author":"M Parlato","year":"2015","unstructured":"Parlato M, Cavaillon JM (2015) Host response biomarkers in the diagnosis of sepsis: a general overview. Methods Mol Biol 1237:149\u2013211","journal-title":"Methods Mol Biol"},{"issue":"7","key":"5520_CR61","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00134-018-5228-3","volume":"44","author":"M Parlato","year":"2018","unstructured":"Parlato M, Philippart F, Rouquette A, Moucadel V, Puchois V, Blein S et al (2018) Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med 44(7):1061\u20131070","journal-title":"Intensive Care Med"},{"issue":"8","key":"5520_CR62","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1097\/CCM.0b013e318251517a","volume":"40","author":"N Layios","year":"2012","unstructured":"Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304\u20132309","journal-title":"Crit Care Med"},{"issue":"9","key":"5520_CR63","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/CCM.0000000000003206","volume":"46","author":"F Mearelli","year":"2018","unstructured":"Mearelli F, Fiotti N, Giansante C, Casarsa C, Orso D, De Helmersen M et al (2018) Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from noninfectious systemic inflammatory response syndrome at emergency department admission: a multicenter prospective study. Crit Care Med 46(9):1421\u20131429","journal-title":"Crit Care Med"},{"issue":"2","key":"5520_CR64","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/cid\/ciu789","volume":"60","author":"AC Kalil","year":"2015","unstructured":"Kalil AC, Syed A, Rupp ME, Chambers H, Vargas L, Maskin A et al (2015) Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study. Clin Infect Dis 60(2):216\u2013222","journal-title":"Clin Infect Dis"},{"key":"5520_CR65","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cmi.2018.04.022","volume":"24","author":"AC Kalil","year":"2018","unstructured":"Kalil AC, Sandkovsky U, Florescu DF (2018) Severe infections in critically ill solid organ transplant recipients. Clin Microbiol Infect 24:1257\u20131263","journal-title":"Clin Microbiol Infect"},{"key":"5520_CR66","unstructured":"NCCN (2018) Clinical practice guidelines in oncology. prevention and treatment of cancer-related infections. version 1.2018. https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf. Accessed 1 Sept 2018"},{"issue":"1","key":"5520_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13613-016-0189-6","volume":"6","author":"D Schnell","year":"2016","unstructured":"Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S et al (2016) Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care 6(1):90","journal-title":"Ann Intensive Care"},{"key":"5520_CR68","unstructured":"European AIDS Clinical Society guidelines. Updated yearly. http:\/\/www.eacsociety.org\/Guidelines.aspx. Accessed 1 Sept 2018"},{"issue":"9990","key":"5520_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","volume":"386","author":"JA Singh","year":"2015","unstructured":"Singh JA, Cameron C, Noorbaloochi S, Cullis T, Tucker M, Christensen R et al (2015) Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 386(9990):258\u2013265","journal-title":"Lancet"},{"issue":"2","key":"5520_CR70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14(2):121\u2013137","journal-title":"Nat Rev Nephrol"},{"key":"5520_CR71","first-page":"20","volume":"4","author":"S Martin","year":"2017","unstructured":"Martin S, Perez A, Aldecoa C (2017) Sepsis and immunosenescence in the elderly patient: a review. Front Med 4:20","journal-title":"Front Med"},{"issue":"1","key":"5520_CR72","doi-asserted-by":"publisher","first-page":"e00024-17","DOI":"10.1128\/CMR.00024-17","volume":"31","author":"P Ramanan","year":"2018","unstructured":"Ramanan P, Bryson AL, Binnicker MJ, Pritt BS, Patel R (2018) Syndromic panel-based testing in clinical microbiology. Clin Microbiol Rev 31(1):e00024-17","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"5520_CR73","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10096-018-3255-1","volume":"37","author":"K van de Groep","year":"2018","unstructured":"van de Groep K, Bos MP, Savelkoul PHM, Rubenjan A, Gazenbeek C, Melchers WJG et al (2018) Development and first evaluation of a novel multiplex real-time PCR on whole blood samples for rapid pathogen identification in critically ill patients with sepsis. Eur J Clin Microbiol Infect Dis 37(7):1333\u20131344","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5520_CR74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2217\/fmb.15.144","volume":"11","author":"E Ruppe","year":"2016","unstructured":"Ruppe E, Baud D, Schicklin S, Guigon G, Schrenzel J (2016) Clinical metagenomics for the management of hospital- and healthcare-acquired pneumonia. Future Microbiol 11(3):427\u2013439","journal-title":"Future Microbiol"},{"key":"5520_CR75","doi-asserted-by":"publisher","DOI":"10.1101\/387548","author":"T Charalampous","year":"2018","unstructured":"Charalampous T, Richardson H, Kay GL, Baldan R, Jeanes C, Rae D et al (2018) Rapid diagnosis of lower respiratory infection using nanopore-based clinical metagenomics. BioRXIV. https:\/\/doi.org\/10.1101\/387548","journal-title":"BioRXIV"},{"issue":"12","key":"5520_CR76","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1164\/rccm.201703-0537LE","volume":"196","author":"KM Pendleton","year":"2017","unstructured":"Pendleton KM, Erb-Downward JR, Bao Y, Branton WR, Falkowski NR, Newton DW et al (2017) Rapid pathogen identification in bacterial pneumonia using real-time metagenomics. Am J Respir Crit Care Med 196(12):1610\u20131612","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5520_CR77","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201706-1097LE","volume":"197","author":"C Langelier","year":"2018","unstructured":"Langelier C, Zinter MS, Kalantar K, Yanik GA, Christenson S, O\u2019Donovan B et al (2018) Metagenomic sequencing detects respiratory pathogens in hematopoietic cellular transplant patients. Am J Respir Crit Care Med 197(4):524\u2013528","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5520_CR78","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmi.2014.12.007","volume":"21","author":"M Le Dorze","year":"2015","unstructured":"Le Dorze M, Gault N, Foucrier A, Ruppe E, Mourvillier B, Woerther PL et al (2015) Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia. Clin Microbiol Infect 21(5):468","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"5520_CR79","doi-asserted-by":"publisher","first-page":"e01672-17","DOI":"10.1128\/JCM.01672-17","volume":"56","author":"JD Lutgring","year":"2018","unstructured":"Lutgring JD, Bittencourt C, McElvania TeKippe E, Cavuoti D, Hollaway R, Burd EM (2018) Evaluation of the accelerate pheno system: results from two academic medical centers. J Clin Microbiol 56(4):e01672-17","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5520_CR80","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciw649","volume":"64","author":"TT Timbrook","year":"2017","unstructured":"Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL (2017) The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64(1):15\u201323","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5520_CR81","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072\u20131083","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5520_CR82","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00134-015-4032-6","volume":"42","author":"JA Roberts","year":"2016","unstructured":"Roberts JA, Taccone FS, Lipman J (2016) Understanding PK\/PD. Intensive Care Med 42(11):1797\u20131800","journal-title":"Intensive Care Med"},{"issue":"5","key":"5520_CR83","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijantimicag.2015.01.007","volume":"45","author":"JJ De Waele","year":"2015","unstructured":"De Waele JJ, Lipman J, Carlier M, Roberts JA (2015) Subtleties in practical application of prolonged infusion of beta-lactam antibiotics. Int J Antimicrob Agents 45(5):461\u2013463","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"5520_CR84","doi-asserted-by":"publisher","first-page":"e02642-16","DOI":"10.1128\/AAC.02642-16","volume":"61","author":"PJ Bergen","year":"2017","unstructured":"Bergen PJ, Bulitta JB, Kirkpatrick CM, Rogers KE, McGregor MJ, Wallis SC et al (2017) Substantial impact of altered pharmacokinetics in critically ill patients on the antibacterial effects of meropenem evaluated via the dynamic hollow-fiber infection model. Antimicrob Agents Chemother 61(5):e02642-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5520_CR85","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00134-017-4780-6","volume":"43","author":"T Tangden","year":"2017","unstructured":"Tangden T, Ramos Martin V, Felton TW, Nielsen EI, Marchand S, Bruggemann RJ et al (2017) The role of infection models and PK\/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Med 43(7):1021\u20131032","journal-title":"Intensive Care Med"},{"issue":"12","key":"5520_CR86","first-page":"3178","volume":"70","author":"A Huttner","year":"2015","unstructured":"Huttner A, Harbarth S, Hope WW, Lipman J, Roberts JA (2015) Therapeutic drug monitoring of the beta-lactam antibiotics: what is the evidence and which patients should we be using it for? J Antimicrob Chemother 70(12):3178\u20133183","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5520_CR87","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1186\/cc12844","volume":"17","author":"W Duszynska","year":"2013","unstructured":"Duszynska W, Taccone FS, Hurkacz M, Kowalska-Krochmal B, Wiela-Hojenska A, Kubler A (2013) Therapeutic drug monitoring of amikacin in septic patients. Crit Care 17(4):R165","journal-title":"Crit Care"},{"issue":"5","key":"5520_CR88","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/jac\/dkv491","volume":"71","author":"A Brasseur","year":"2016","unstructured":"Brasseur A, Hites M, Roisin S, Cotton F, Vincent JL, De Backer D et al (2016) A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study. J Antimicrob Chemother 71(5):1386\u20131394","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5520_CR89","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/jac\/dku569","volume":"70","author":"O Pajot","year":"2015","unstructured":"Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A et al (2015) Impact of imipenem and amikacin pharmacokinetic\/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia. J Antimicrob Chemother 70(5):1487\u20131494","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"5520_CR90","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/phar.1638","volume":"35","author":"JP Prybylski","year":"2015","unstructured":"Prybylski JP (2015) Vancomycin trough concentration as a predictor of clinical outcomes in patients with Staphylococcus aureus bacteremia: a meta-analysis of observational studies. Pharmacotherapy 35(10):889\u2013898","journal-title":"Pharmacotherapy"},{"issue":"5","key":"5520_CR91","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/jac\/dkt523","volume":"69","author":"G Wong","year":"2014","unstructured":"Wong G, Brinkman A, Benefield RJ, Carlier M, De Waele JJ, El Helali N et al (2014) An international, multicentre survey of beta-lactam antibiotic therapeutic drug monitoring practice in intensive care units. J Antimicrob Chemother 69(5):1416\u20131423","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5520_CR92","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jac\/dkx427","volume":"73","author":"JW Mouton","year":"2018","unstructured":"Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J (2018) MIC-based dose adjustment: facts and fables. J Antimicrob Chemother 73(3):564\u2013568","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5520_CR93","first-page":"497","volume":"81","author":"M Beumier","year":"2015","unstructured":"Beumier M, Casu GS, Hites M, Wolff F, Cotton F, Vincent JL et al (2015) Elevated beta-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol 81(5):497\u2013506","journal-title":"Minerva Anestesiol"},{"issue":"10","key":"5520_CR94","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/jac\/dkx209","volume":"72","author":"S Imani","year":"2017","unstructured":"Imani S, Buscher H, Marriott D, Gentili S, Sandaradura I (2017) Too much of a good thing: a retrospective study of beta-lactam concentration-toxicity relationships. J Antimicrob Chemother 72(10):2891\u20132897","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5520_CR95","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","volume":"18","author":"A Torres","year":"2018","unstructured":"Torres A, Zhong N, Pachl J, Timsit JF, Kollef M, Chen Z et al (2018) Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Lancet Infect Dis 18(3):285\u2013295","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"5520_CR96","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2018.12163","volume":"320","author":"PNA Harris","year":"2018","unstructured":"Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M et al (2018) Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA 320(10):984\u2013994","journal-title":"JAMA"},{"issue":"10","key":"5520_CR97","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00134-018-5360-0","volume":"44","author":"G Bertolini","year":"2018","unstructured":"Bertolini G, Nattino G, Tascini C, Poole D, Viaggi B, Carrara G et al (2018) Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection. Intensive Care Med 44(10):1709\u20131719","journal-title":"Intensive Care Med"},{"issue":"11","key":"5520_CR98","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/cid\/cit112","volume":"56","author":"KP Murray","year":"2013","unstructured":"Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P et al (2013) Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration\u2009>\u20091\u00a0mg\/L: a matched cohort study. Clin Infect Dis 56(11):1562\u20131569","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5520_CR99","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/cid\/cir895","volume":"54","author":"RG Wunderink","year":"2012","unstructured":"Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A et al (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54(5):621\u2013629","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5520_CR100","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cmi.2017.06.010","volume":"23","author":"M Abbas","year":"2017","unstructured":"Abbas M, Paul M, Huttner A (2017) New and improved? A review of novel antibiotics for Gram-positive bacteria. Clin Microbiol Infect 23(10):697\u2013703","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5520_CR101","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"PD Tamma","year":"2012","unstructured":"Tamma PD, Cosgrove SE, Maragakis LL (2012) Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25(3):450\u2013470","journal-title":"Clin Microbiol Rev"},{"key":"5520_CR102","first-page":"CD003344","volume":"1","author":"M Paul","year":"2014","unstructured":"Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L (2014) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 1:CD003344","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"5520_CR103","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","volume":"38","author":"A Kumar","year":"2010","unstructured":"Kumar A, Safdar N, Kethireddy S, Chateau D (2010) A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study. Crit Care Med 38(8):1651\u20131664","journal-title":"Crit Care Med"},{"issue":"12","key":"5520_CR104","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/jac\/dkx315","volume":"72","author":"M Ripa","year":"2017","unstructured":"Ripa M, Rodriguez-Nunez O, Cardozo C, Naharro-Abellan A, Almela M, Marco F et al (2017) Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis. J Antimicrob Chemother 72(12):3443\u20133452","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5520_CR105","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A et al (2014) Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58(4):2322\u20132328","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5520_CR106","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M et al (2015) Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70(7):2133\u20132143","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5520_CR107","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","volume":"22","author":"M Falcone","year":"2016","unstructured":"Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A et al (2016) Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect 22(5):444\u2013450","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5520_CR108","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","volume":"17","author":"B Gutierrez-Gutierrez","year":"2017","unstructured":"Gutierrez-Gutierrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Pano-Pardo JR et al (2017) Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 17(7):726\u2013734","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"5520_CR109","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","volume":"55","author":"M Tumbarello","year":"2012","unstructured":"Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A et al (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55(7):943\u2013950","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5520_CR110","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1017\/S095026881200194X","volume":"141","author":"H Aydemir","year":"2013","unstructured":"Aydemir H, Akduman D, Piskin N, Comert F, Horuz E, Terzi A et al (2013) Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 141(6):1214\u20131222","journal-title":"Epidemiol Infect"},{"issue":"3","key":"5520_CR111","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/cit253","volume":"57","author":"E Durante-Mangoni","year":"2013","unstructured":"Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P et al (2013) Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 57(3):349\u2013358","journal-title":"Clin Infect Dis"},{"issue":"9","key":"5520_CR112","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1128\/AAC.02435-13","volume":"58","author":"R Sirijatuphat","year":"2014","unstructured":"Sirijatuphat R, Thamlikitkul V (2014) Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother 58(9):5598\u20135601","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5520_CR113","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","volume":"18","author":"M Paul","year":"2018","unstructured":"Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD et al (2018) Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis 18(4):391\u2013400","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5520_CR114","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/dkw377","volume":"72","author":"O Zusman","year":"2017","unstructured":"Zusman O, Altunin S, Koppel F, Dishon Benattar Y, Gedik H, Paul M (2017) Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis. J Antimicrob Chemother 72(1):29\u201339","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5520_CR115","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/ijccm.IJCCM_302_17","volume":"22","author":"D Makris","year":"2018","unstructured":"Makris D, Petinaki E, Tsolaki V, Manoulakas E, Mantzarlis K, Apostolopoulou O et al (2018) Colistin versus colistin combined with ampicillin-sulbactam for multiresistant Acinetobacter baumannii ventilator-associated pneumonia treatment: an open-label prospective study. Indian J Crit Care Med 22(2):67\u201377","journal-title":"Indian J Crit Care Med"},{"issue":"4","key":"5520_CR116","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijantimicag.2017.12.020","volume":"51","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME (2018) Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis. Int J Antimicrob Agents 51(4):535\u2013547","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"5520_CR117","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cmi.2015.05.002","volume":"21","author":"FB Sime","year":"2015","unstructured":"Sime FB, Roberts MS, Roberts JA (2015) Optimization of dosing regimens and dosing in special populations. Clin Microbiol Infect 21(10):886\u2013893","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5520_CR118","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","volume":"18","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME (2018) Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 18(1):108\u2013120","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5520_CR119","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijantimicag.2015.10.019","volume":"47","author":"JJ Hao","year":"2016","unstructured":"Hao JJ, Chen H, Zhou JX (2016) Continuous versus intermittent infusion of vancomycin in adult patients: a systematic review and meta-analysis. Int J Antimicrob Agents 47(1):28\u201335","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"5520_CR120","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/cid\/civ1199","volume":"62","author":"A Tabah","year":"2016","unstructured":"Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J et al (2016) A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 62(8):1009\u20131017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5520_CR121","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmi.2015.03.013","volume":"21","author":"E Weiss","year":"2015","unstructured":"Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J et al (2015) Elaboration of a consensual definition of de-escalation allowing a ranking of beta-lactams. Clin Microbiol Infect. 21(7):649","journal-title":"Clin Microbiol Infect"},{"key":"5520_CR122","first-page":"CD007934","volume":"3","author":"BN Silva","year":"2013","unstructured":"Silva BN, Andriolo RB, Atallah AN, Salomao R (2013) De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 3:CD007934","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5520_CR123","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00134-013-3148-9","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP et al (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40(1):41\u201349","journal-title":"Intensive Care Med"},{"issue":"12","key":"5520_CR124","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cmi.2016.05.023","volume":"22","author":"M Paul","year":"2016","unstructured":"Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect 22(12):960\u2013967","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"5520_CR125","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanese J, Jaber S et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40(10):1399\u20131408","journal-title":"Intensive Care Med"},{"issue":"12","key":"5520_CR126","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00134-016-4448-7","volume":"42","author":"E Weiss","year":"2016","unstructured":"Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C et al (2016) De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition. Intensive Care Med 42(12):2098\u20132100","journal-title":"Intensive Care Med"},{"issue":"6","key":"5520_CR127","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00134-016-4301-z","volume":"42","author":"L De Bus","year":"2016","unstructured":"De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J et al (2016) Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med 42(6):1029\u20131039","journal-title":"Intensive Care Med"},{"issue":"8","key":"5520_CR128","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cmi.2018.05.020","volume":"24","author":"E Ruppe","year":"2018","unstructured":"Ruppe E, Martin-Loeches I, Rouze A, Levast B, Ferry T, Timsit JF (2018) What\u2019s new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation. Clin Microbiol Infect 24(8):803\u2013805","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5520_CR129","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jtbi.2007.08.011","volume":"249","author":"EM D\u2019Agata","year":"2007","unstructured":"D\u2019Agata EM, Magal P, Olivier D, Ruan S, Webb GF (2007) Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. J Theor Biol 249(3):487\u2013499","journal-title":"J Theor Biol"},{"issue":"19","key":"5520_CR130","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D et al (2003) Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588\u20132598","journal-title":"JAMA"},{"issue":"7","key":"5520_CR131","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/ciw870","volume":"64","author":"M Klompas","year":"2017","unstructured":"Klompas M, Li L, Menchaca JT, Gruber S (2017) Ultra-short-course antibiotics for patients with suspected ventilator-associated pneumonia but minimal and stable ventilator settings. Clin Infect Dis 64(7):870\u2013876","journal-title":"Clin Infect Dis"},{"issue":"9840","key":"5520_CR132","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","volume":"380","author":"T Sandberg","year":"2012","unstructured":"Sandberg T, Skoog G, Hermansson AB, Kahlmeter G, Kuylenstierna N, Lannergard A et al (2012) Ciprofloxacin for 7\u00a0days versus 14\u00a0days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 380(9840):484\u2013490","journal-title":"Lancet"},{"issue":"2","key":"5520_CR133","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/cid\/cix767","volume":"66","author":"D Chotiprasitsakul","year":"2018","unstructured":"Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT et al (2018) Comparing the outcomes of adults with enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis 66(2):172\u2013177","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5520_CR134","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","volume":"44","author":"P Montravers","year":"2018","unstructured":"Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farese M, Seguin P et al (2018) Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 44(3):300\u2013310","journal-title":"Intensive Care Med"},{"issue":"5","key":"5520_CR135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.12788\/jhm.2905","volume":"13","author":"S Royer","year":"2018","unstructured":"Royer S, DeMerle KM, Dickson RP, Prescott HC (2018) Shorter versus longer courses of antibiotics for infection in hospitalized patients: a systematic review and meta-analysis. J Hosp Med 13(5):336\u2013342","journal-title":"J Hosp Med"},{"issue":"6","key":"5520_CR136","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/phar.2118","volume":"38","author":"AM Hanretty","year":"2018","unstructured":"Hanretty AM, Gallagher JC (2018) Shortened courses of antibiotics for bacterial infections: a systematic review of randomized controlled trials. Pharmacotherapy. 38(6):674\u2013687","journal-title":"Pharmacotherapy"},{"issue":"3","key":"5520_CR137","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJMoa1802670","volume":"379","author":"DT Huang","year":"2018","unstructured":"Huang DT, Yealy DM, Filbin MR, Brown AM, Chang CH, Doi Y et al (2018) Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med 379(3):236\u2013249","journal-title":"N Engl J Med"},{"issue":"1","key":"5520_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","volume":"18","author":"JE Mazuski","year":"2017","unstructured":"Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR et al (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect 18(1):1\u201376","journal-title":"Surg Infect"},{"issue":"Suppl 6","key":"5520_CR139","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M et al (2011) Guidelines for the management of adult lower respiratory tract infections\u2014full version. Clin Microbiol Infect 17(Suppl 6):E1\u2013E59","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"5520_CR140","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al (2007) Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27\u2013S72","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5520_CR141","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103\u2013e120","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5520_CR142","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H et al (2017) International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 50(3):1700582","journal-title":"Eur Respir J"},{"issue":"15","key":"5520_CR143","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"EY Klein","year":"2018","unstructured":"Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA et al (2018) Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA 115(15):E3463\u2013E3470","journal-title":"Proc Natl Acad Sci USA"},{"key":"5520_CR144","unstructured":"ECDC. Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2017. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Final_2017_EAAD_ESAC-Net_Summary-edited%20-%20FINALwith%20erratum.pdf2017. Accessed 13 Oct 2018"},{"issue":"6","key":"5520_CR145","doi-asserted-by":"publisher","first-page":"R218","DOI":"10.1186\/cc11862","volume":"16","author":"MH Kollef","year":"2012","unstructured":"Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K et al (2012) A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care 16(6):R218","journal-title":"Crit Care"},{"issue":"7","key":"5520_CR146","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00268-004-7505-2","volume":"28","author":"M Schein","year":"2004","unstructured":"Schein M, Marshall J (2004) Source control for surgical infections. World J Surg 28(7):638\u2013645","journal-title":"World J Surg"},{"issue":"1","key":"5520_CR147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CCM.0000000000002011","volume":"45","author":"ML Martinez","year":"2017","unstructured":"Martinez ML, Ferrer R, Torrents E, Guillamat-Prats R, Goma G, Suarez D et al (2017) Impact of source control in patients with severe sepsis and septic shock. Crit Care Med 45(1):11\u201319","journal-title":"Crit Care Med"},{"issue":"1","key":"5520_CR148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjsurg.2012.08.008","volume":"206","author":"WN Chao","year":"2013","unstructured":"Chao WN, Tsai CF, Chang HR, Chan KS, Su CH, Lee YT et al (2013) Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg 206(1):32\u201339","journal-title":"Am J Surg"},{"issue":"7","key":"5520_CR149","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/apt.13764","volume":"44","author":"CJ Karvellas","year":"2016","unstructured":"Karvellas CJ, Abraldes JG, Zepeda-Gomez S, Moffat DC, Mirzanejad Y, Vazquez-Grande G et al (2016) The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther 44(7):755\u2013766","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"5520_CR150","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos F, Ruddel H, Thomas-Ruddel D, Schwarzkopf D, Pausch C, Harbarth S et al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602\u20131612","journal-title":"Intensive Care Med"},{"issue":"2","key":"5520_CR151","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos F, Thomas-Ruddel D, Ruddel H, Engel C, Schwarzkopf D, Marshall JC et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18(2):R42","journal-title":"Crit Care"},{"issue":"3","key":"5520_CR152","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/cc13854","volume":"18","author":"T Azuhata","year":"2014","unstructured":"Azuhata T, Kinoshita K, Kawano D, Komatsu T, Sakurai A, Chiba Y et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18(3):R87","journal-title":"Crit Care"},{"issue":"5","key":"5520_CR153","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00134-008-1373-4","volume":"35","author":"A Boyer","year":"2009","unstructured":"Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G et al (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35(5):847\u2013853","journal-title":"Intensive Care Med"},{"issue":"8","key":"5520_CR154","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1128\/AAC.00825-16","volume":"60","author":"S Karanika","year":"2016","unstructured":"Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E (2016) Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 60(8):4840\u20134852","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5520_CR155","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Dobele S et al (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 17(9):990\u20131001","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"5520_CR156","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","volume":"23","author":"OJ Dyar","year":"2017","unstructured":"Dyar OJ, Huttner B, Schouten J, Pulcini C (2017) What is antimicrobial stewardship? Clin Microbiol Infect 23(11):793\u2013798","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5520_CR157","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmi.2018.03.033","volume":"25","author":"C Pulcini","year":"2018","unstructured":"Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA et al (2018) Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect 25(1):20\u201325","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"5520_CR158","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00134-017-4682-7","volume":"43","author":"MH Kollef","year":"2017","unstructured":"Kollef MH, Bassetti M, Francois B, Burnham J, Dimopoulos G, Garnacho-Montero J et al (2017) The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med 43(9):1187\u20131197","journal-title":"Intensive Care Med"},{"issue":"2","key":"5520_CR159","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00134-017-5036-1","volume":"44","author":"JJ De Waele","year":"2018","unstructured":"De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D et al (2018) Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM\/ESCMID\/WAAAR round table on multi-drug resistance. Intensive Care Med 44(2):189\u2013196","journal-title":"Intensive Care Med"},{"key":"5520_CR160","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1748-5908-8-35","volume":"8","author":"SA Flottorp","year":"2013","unstructured":"Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M et al (2013) A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci IS 8:35","journal-title":"Implement Sci IS"},{"issue":"9","key":"5520_CR161","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-017-5034-3","volume":"44","author":"S Bailly","year":"2018","unstructured":"Bailly S, Meyfroidt G, Timsit JF (2018) What\u2019s new in ICU in 2050: big data and machine learning. Intensive Care Med 44(9):1524\u20131527","journal-title":"Intensive Care Med"},{"issue":"1","key":"5520_CR162","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13613-018-0363-0","volume":"8","author":"JIF Salluh","year":"2018","unstructured":"Salluh JIF, Chiche JD, Reis CE, Soares M (2018) New perspectives to improve critical care benchmarking. Ann Inten Care 8(1):17","journal-title":"Ann Inten Care"},{"issue":"1","key":"5520_CR163","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5935\/0103-507X.20160008","volume":"28","author":"E Naidus","year":"2016","unstructured":"Naidus E, Celi LA (2016) Big data in healthcare: are we close to it? Rev Bras Ter Intensiva 28(1):8\u201310","journal-title":"Rev Bras Ter Intensiva"},{"issue":"5","key":"5520_CR164","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.mcna.2018.05.007","volume":"102","author":"DN Bremmer","year":"2018","unstructured":"Bremmer DN, Trienski TL, Walsh TL, Moffa MA (2018) Role of technology in antimicrobial stewardship. Med Clin N Am 102(5):955\u2013963","journal-title":"Med Clin N Am"},{"issue":"9","key":"5520_CR165","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11908-018-0637-6","volume":"20","author":"J Emberger","year":"2018","unstructured":"Emberger J, Tassone D, Stevens MP, Markley JD (2018) The current state of antimicrobial stewardship: challenges, successes, and future directions. Curr Infect Dis Rep 20(9):31","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"5520_CR166","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.idc.2017.05.002","volume":"31","author":"SB Doernberg","year":"2017","unstructured":"Doernberg SB, Chambers HF (2017) Antimicrobial stewardship approaches in the intensive care unit. Infect Dis Clin N Am 31(3):513\u2013534","journal-title":"Infect Dis Clin N Am"},{"issue":"suppl_2","key":"5520_CR167","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1093\/cid\/cix112","volume":"64","author":"N Teerawattanapong","year":"2017","unstructured":"Teerawattanapong N, Kengkla K, Dilokthornsakul P, Saokaew S, Apisarnthanarak A, Chaiyakunapruk N (2017) Prevention and control of multidrug-resistant Gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. Clin Infect Dis 64(suppl_2):S51\u2013S60","journal-title":"Clin Infect Dis"},{"key":"5520_CR168","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00134-018-5309-3","volume":"44","author":"E Ruppe","year":"2018","unstructured":"Ruppe E, Lisboa T, Barbier F (2018) The gut microbiota of critically ill patients: first steps in an unexplored world. Intensive Care Med 44:1561\u20131564","journal-title":"Intensive Care Med"},{"issue":"4","key":"5520_CR169","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/infdis\/jix604","volume":"217","author":"J de Gunzburg","year":"2018","unstructured":"de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppe E et al (2018) Protection of the human gut microbiome from antibiotics. J Infect Dis 217(4):628\u2013636","journal-title":"J Infect Dis"},{"issue":"2","key":"5520_CR170","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(16)30119-4","volume":"2","author":"BW Haak","year":"2017","unstructured":"Haak BW, Wiersinga WJ (2017) The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol 2(2):135\u2013143","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5520_CR171","unstructured":"World Health Organization. Antimicrobial resistance\u2014Global report of surveillance. http:\/\/www.who.int\/antimicrobial-resistance\/publications\/surveillancereport\/en\/. 2014"},{"key":"5520_CR172","unstructured":"European Center for Disease Control and Prevention. European Antimicrobial Resistance Surveillance Network (EARS-Net)\u2014Annual report. http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance). 2016"},{"issue":"5","key":"5520_CR173","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s13054-014-0480-6","volume":"18","author":"CE Luyt","year":"2014","unstructured":"Luyt CE, Brechot N, Trouillet JL, Chastre J (2014) Antibiotic stewardship in the intensive care unit. Crit Care 18(5):480","journal-title":"Crit Care"},{"issue":"4","key":"5520_CR174","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijantimicag.2016.01.009","volume":"47","author":"AS Alobaid","year":"2016","unstructured":"Alobaid AS, Hites M, Lipman J, Taccone FS, Roberts JA (2016) Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review. Int J Antimicrob Agents 47(4):259\u2013268","journal-title":"Int J Antimicrob Agents"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-019-05520-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-019-05520-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-019-05520-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:22:08Z","timestamp":1744176128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-019-05520-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":174,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,27]]}},"alternative-id":["5520"],"URL":"https:\/\/doi.org\/10.1007\/s00134-019-05520-5","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Kollef\u2019s effort was supported by the Barnes-Jewish Hospital Foundation. Dr. Barbier received consulting fees, speaker fees, and conference invitation from MSD, and conference invitation from Pfizer. Dr. De\u00a0Waele\u00a0has been consultant for Accelerate Diagnostics, Bayer Healthcare, Grifols, MSD, and Pfizer (all honoraria paid to institution). Dr. Timsit received fees for scientific advisory boards from Pfizer, Bayer pharma, Merck, Nabriva and received fees for lectures from Biomerieux, Pfizer, Merck, Gilead. Dr. Rodr\u00edguez-Ba\u00f1o received honoraria for accredited educational activities from Merck and for coordination of a non-product-related research project by Astra-Zeneca. Dr. Rupp\u00e9 received speaker fees from MSD, Sanofi, and Mobidiag, fees for scientific advisory board from Pathoquest and MaaT Pharma, and consulting fees from DaVolterra. Dr. Daikos reports grants from Pfizer, Gilead, and honoraria from Pfizer, Achaogen, MSD, and Rempex, outside of this work. Dr. Kipnis received fees for scientific advisory boards, lectures, and conference invitation from MSD, for lectures and conference invitations from Pfizer and Fresenius, and conference invitations from LFB and Gilead. Dr. Weiss reports speaker fees form Baxter, MSD, and Gilead, congress and travel reimbursements from MSD and Eumedica, and having participated in an advisory board from Biomerieux.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}